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ture transports oxygen, nutrients, and waste, and also produces 
local growth factors and cytokines that communicate with ad-
ipose tissue (Cao, 2014). In turn, adipose tissue modulates the 
vasculature by secreting both pro- and anti-angiogenic factors 
(Cao, 2014; Christiaens and Lijnen, 2010). Due to these char-
acteristics of adipose tissue, chemicals affecting it may cause a 
wide variety of adverse health effects throughout the body.
A wide variety of animal models, including fruit flies, dogs, 
cats, pigs, rabbits, hamsters, squirrels, mice, rats, and primates, 
have been used to study adipose tissue (Lai et al., 2014). Al-
though animal models contain all components of the in vivo 
adipose tissue, the results obtained with animal models trans-
late poorly to humans (Lai et al., 2014; Bergen and Mersmann, 
2005; Chandrasekera and Pippin, 2014), especially as the com-
plex pathways of lipid metabolism are mostly species-specif-
1  Introduction
As obesity, both in adults and children, has reached epidem-
ic proportions globally, the prevalence of associated diseases 
has increased correspondingly. In addition to type 2 diabetes, 
obesity and overweight are associated with cancer, sleep apnea, 
asthma, degenerative joint disease, hypertension, renal failure, 
stroke, and cardiovascular disease (Switzer et al., 2013; van 
Baak, 2013; Pi-Sunyer, 2009).
In addition to storing energy, adipose tissue is a dynam-
ic endocrine organ secreting many different bioactive factors 
that control insulin sensitivity, energy metabolism, immune 
responses, and cardiovascular homeostasis (Gu and Xu, 2013; 
Kershaw and Flier, 2004). Adipose tissue is also one of the 
most vascularized tissues in the body (Cao, 2013). The vascula-
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Abstract
Besides being an energy store, adipose tissue is an endocrine organ closely associated with the vascular system. Human 
relevant in vitro models are needed to study adipose tissue and related diseases. Vasculature plays a central role in the 
development and inhibition of adipose tissue-related diseases.
Here, an adipocyte culture was established from hASC (human adipose stromal cells), and a vascularized adipose tissue 
model was established from hASC and HUVEC (human umbilical cord vein endothelial cells) co-culture, utilizing the 
same differentiation procedure. Comparing these models allowed analysis of the effect of vascularization on adipocytes. 
Both models were characterized on gene (adipocyte and vasculature-related), protein (von Willebrand factor, collagen 
IV, CD140b and CD144, secretion of leptin, adiponectin and FABP4), and functional (triglyceride accumulation, glucose 
uptake, and lipolysis) levels. Additionally, the vascularized adipose tissue model was exposed to chemicals with known 
effects on adipogenesis and angiogenesis (rosiglitazone, chlorpyrifos, prochloraz, mancozeb, butylparaben, 15-deoxy-
∆12,14-prostaglandin J2, bisphenol A, bis-(2-ethylhexyl) phthalate, tributyltin chloride) to compare their effects to the 
literature. The in vitro vascularized adipose tissue model demonstrated the presence of functional adipocytes and an 
extensive vascular network, displaying relevant gene and protein markers. Insulin induced glucose uptake, inhibited 
lipolysis, and influenced vasculature-related genes. The presence of vasculature led to a faster lipolysis inhibition by 
insulin and modulated responses to chemicals. This novel, thoroughly characterized, vascularized adipose tissue model 
is a promising new tool for studying adipose tissue as well as the effects of chemicals on adipogenesis and angiogenesis 
in adipose tissue. 
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution and reproduction in any medium, provi-
ded the original work is appropriately cited. 
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2  Materials and methods∗
Ethical considerations
This in vitro study conforms to the ethical principles outlined in 
the Declaration of Helsinki. Human adipose tissue samples were 
obtained from excess material of surgical operations, and human 
umbilical cords were received from caesarean sections with writ-
ten informed consent at Tampere University Hospital, Tampere, 
Finland. The use of human adipose stromal cells (hASC) and hu-
man umbilical cord endothelial cells (HUVEC) was approved by 
the Ethics Committee of the Pirkanmaa Hospital District, Tam-
pere, Finland (permit numbers: R15161 and R15033). 
Cells
hASC used in the study were heterogenous cell populations ob-
tained by isolating the stromal vascular fraction cells from human 
adipose tissue. HUVEC used in the study were isolated from um-
bilical cords. hASC and HUVEC were isolated as described by 
Sarkanen et al. (2012b). Before cryopreservation, all cell batches 
were tested for mycoplasma using Mycoplasma kit (MycoAlert® 
Detection Kit, Lonza Group LTD, Basel, Switzerland). Only My-
coplasma-free cell batches were used. hASC were characterized 
for markers CD73, CD90, and CD105 (BD biosciences, Frank-
lin Lakes, NJ, USA) using a flow cytometer FACSCanto II (BD 
biosciences) as published previously (Huttala et al., 2015). hASC 
were expanded in hASC medium (Tab. 1) and HUVEC in Endo-
thelial Cell Growth Medium-2 BulletKit (EGM-2, Lonza). In the 
co-cultures, hASC were at passage 2 and HUVEC at passage 4.
Adipose tissue extract
Adipose tissue extract (ATE) was produced as described previ-
ously (Huttala et al., 2018). Briefly, a human adipose tissue sam-
ple was manually cut into small pieces and incubated in DMEM/
F12 (Gibco, Carlsbad, CA, USA) for 24 h in 37°C. The resulting 
extract was filtered through a 0.2 µm filter. The protein content 
of the extract was determined with Pierce™ BCA Protein Assay 
Kit (Thermo Fisher Scientific, Waltham, MA, USA) according 
to the manufacturer’s instructions using bovine serum albumin 
(BSA) as a standard. Results were measured after 30 min incuba-
tion at 37°C at 562 nm with Varioskan™ Flash Multimode Read-
er (Thermo Fisher Scientific). 
Vascularized adipose tissue model
The culturing scheme of the vascularized adipose tissue model 
can be seen in Table 2 and the different media compositions in 
Table 1. The undifferentiated control contained hASC and HU-
VEC cells cultured in basic media corresponding to the media 
used for differentiation (hASC medium corresponding to ATE 
medium, SFM corresponding to SM and MM). The adipocyte 
culture and the vascularized adipose tissue model were produced 
using a protocol published previously as “protocol 7” (Hutta-
ic (Lai et al., 2014; Bergen and Mersmann, 2005; Chandrase-
kera and Pippin, 2014). Thus, new human cell-based models 
are needed to replace animal models to support 3R principles 
and to offer biologically relevant tools for research of human 
adipose tissue-related diseases.
Adipogenic cocktail treatments, which include insulin, 
isobutylmethylxanthine, biotin, pantothenate, dexamethasone, 
and thiazolidinediones, have been problematic in developing 
vascularized adipose tissue as they have multiple negative ef-
fects on endothelial cells, including delayed growth (Kang et 
al., 2009). Volz et al. (2018) developed an elegant, serum-free 
defined medium for in vitro vascularized adipose tissue, but 
the need to pre-differentiate the adipocytes prior to combining 
the endothelial cells into the culture hampers its usability and 
lengthens the culture time.
In the present study, a novel vascularized human adipose tis-
sue model was established. This model is based on protocols of 
our previously established insulin-sensitive adipocytes (Hutta-
la et al., 2016) and vascularized adipose tissue model (Huttala 
et al., 2018). All these models utilize adipose tissue extract 
(ATE), which is a natural adipogenesis inducer that also enables 
angiogenesis (Sarkanen et al., 2012a). The novel vascularized 
adipose tissue model, established from human adipose stromal 
cells (hASC) and human umbilical cord vein endothelial cell 
(HUVEC) co-culture, was compared to adipocyte culture es-
tablished from hASC, using the same differentiation procedure. 
The use of the same differentiation procedure for both models 
provides a reliable model pair to study the effect of vasculature 
on adipocytes. Using the vascularized adipose tissue model, the 
effects of chemicals on both angiogenesis and adipogenesis can 
be investigated simultaneously. 
In order to ensure that the vascularized adipose tissue model 
is suitable for human adipose tissue research, it was character-
ized comprehensively. The gene expression of markers of adi-
pocyte tissue and vasculature, secretion of adipokines known to 
be produced in in vivo white adipose tissue (leptin, FABP4, and 
adiponectin), accumulation of triglycerides, insulin responses 
(inhibition of lipolysis and induction of glucose uptake), and 
vascular formation were investigated. In addition, the func-
tion of the vascularized adipose tissue model was confirmed 
by challenging it with reference chemicals that have known 
effects on adipogenesis and adipose tissue angiogenesis. Nine 
chemicals (rosiglitazone, chlorpyrifos, prochloraz, mancozeb, 
butylparaben, 15-deoxy-∆12,14-prostaglandin J2, bisphenol A, 
bis-(2-ethylhexyl) phthalate, and tributyltin chloride) were 
used to test the adipogenic and angiogenic responses of the 
vascularized adipose tissue. Three of the chemicals (rosiglita-
zone, chlorpyrifos, and prochloraz) were employed on both the 
adipocyte culture and the vascularized adipose tissue model to 
determine the contribution of the vasculature to the chemicals’ 
effects. 
Abbreviations 
hASC, human adipose stromal cells; HUVEC, human umbilical cord vein endothelial cells; EC50, half maximal effective concentration; ATE, adipose tissue extract;  
BSA, bovine serum albumin; ECM, extracellular matrix; ins, insulin; SFM, serum free medium; ATEm, ATE medium; SM, stimulation medium; MM, maintenance medium (SM 
without insulin and troglitazone)
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vascularized adipose tissue model, the HUVEC (4400 cells/cm2) 
were plated on day 7 by first removing 100 µl of culture media 
from the wells and then adding the HUVEC in 100 µl of EGM-2 
(Lonza). Analyses were performed on day 14.
Effect of chemicals on the properties and functions of  
the vascularized adipose tissue model
Table 3 shows the chemicals used and their final concentrations 
in the test. The vascularized adipose tissue model was exposed to 
test chemicals on day 8 to investigate the effect of study chem-
la et al., 2016) with some modifications: one additional medi-
um change and one additional macromolecule component (Fi-
coll-Paque Plus) were included. Day 0, hASC were plated in 
hASC medium at a density of 20,000 cells/cm2. TrypLE™ Ex-
press (Gibco) was used for the detachment of cells. On days 1, 
4, 8 and 11 the medium was changed according to Table 2. Total 
medium volume used per well in a 48 well plate was 500 µl. 
After each medium change macromolecule Ficoll-Paque Plus 
(GE Health care, Buckinghamshire, UK) was added into each 
well at a volume of 25 µl per 500 µl of culture medium. For the 
Tab. 1: List of cell culture media and their components and manufacturers
Medium
hASC medium
Serum free medium
ATE medium
Stimulation medium 
Maintenance medium 
(stimulation medium 
without insulin  
and troglitazone)
Abbreviation
-
SFM 
 
 
 
 
 
 
 
 
ATEm
SM
 
MM
Content
DMEM/F12
10% human serum
2 mM L-glutamine
DMEM/F12
2.56 mM L-glutamine
0.1 nM 3,3’,5-triiodo-L-thyronine sodium salt
ITSTM Premix:
- 1.15 µM: 6.65µg/ml insulin
- 6.65 µg/ml transferrin
- 6.65 ng/ml selenious acid
1% bovine serum albumin (BSA)
2.8 mM sodium pyruvate
1800 µg/ml adipose tissue extract (ATE)
DMEM/F12
10% human serum
2 mM L-glutamine
50 IU/ml penicillin/ 50 µg/ml streptomycin
Serum free medium supplemented with 200 µg/ml 
ascorbic acid
0.5 µg/ml heparin
5.5 µM: 2 µg/ml hydrocortisone/ cortisol
10 ng/ml vascular endothelial growth factor
1 ng/ml fibroblast growth factor β
9 µM troglitazone
DMEM/F12
2.56 mM L-glutamine
0.1 nM 3,3’,5-triiodo-L-thyronine sodium salt
6.65 µg/ml transferrin
6.65 ng/ml selenious acid
1% BSA
2.8 mM sodium pyruvate
200 µg/ml ascorbic acid
0.5 µg/ml heparin
2 µg/ml hydrocortisone
10 ng/ml VEGF
1 ng/ml FGF2
Manufacturer
Gibco
PAA laboratories 
Gibco
Gibco
Gibco
Sigma
BD biosciences
PAA laboratories
Gibco
-
Gibco
PAA laboratories
Gibco
Gibco 
Sigma
Sigma
Sigma
R&D Systems
R&D Systems
Sigma
Gibco
Gibco
Sigma
Sigma
Sigma
PAA laboratories
Gibco
Sigma
Sigma
Sigma
R&D Systems
R&D Systems
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of vasculature were assessed. Two independent experiments 
with two replicates were performed. Half maximal effective con-
centration (EC50) values were calculated using GraphPad Prism 
6.05 software.
Mitochondrial activity, triglyceride accumulation,  
and protein secretion
Mitochondrial activity, as an index of the number of living cells, 
was analyzed by WST-1 (Roche Diagnostics, Basel, Switzerland) 
after one-hour incubation. Absorbance was measured at 450 nm 
with a Varioskan Flash Multimode Reader (Thermo Fischer Sci-
entific). The WST-1 results are shown without normalization to 
depict the cell numbers as well as mitochondrial activity. 
Triglyceride accumulation in the cell cultures was measured 
with AdipoRed assay reagent (Lonza) after 10 min incubation 
at room temperature subsequent to the WST-1 analysis. Fluores-
cence was measured with a Varioskan Flash Multimode Reader 
(Thermo Fischer Scientific), with excitation at 485 nm and emis-
sion at 572 nm. The amount of accumulated triglyceride per cell 
icals on both adipogenesis and angiogenesis. After one week of 
exposure, the analyses (viability/mitochondrial activity, lipid ac-
cumulation, amount of vasculature, and with three chemicals also 
the adipocyte-related gene expression) were performed. The ac-
tual purity of the chemicals was used in the dilution calculations. 
Vehicle controls for all chemicals were exposed to the same con-
centration of solvent that was present in the chemical dilutions.
Both the adipocyte culture and the vascularized adipose tissue 
model were exposed to three chemicals (rosiglitazone, chlorpy-
rifos, and prochloraz) on day 8 to investigate the impact of vas-
cularization on the effects of the chemicals on adipocyte lipid 
accumulation and adipocyte related gene expression. The impact 
of chemicals on angiogenesis was also investigated. Three inde-
pendent experiments with two replicates were performed. 
To further evaluate the performance of the vascularized adi-
pose tissue model, it was challenged with mancozeb, butylpara-
ben, 15-deoxy-Δ12,14-prostaglandin J2, bisphenol A, bis-(2-eth-
ylhexyl) phthalate, and tributyltin chloride and their effects on 
lipid accumulation, viability/mitochondrial activity, and amount 
Tab. 2: Culture schedule for the undifferentiated control, the adipocyte culture, and the vascularized adipose tissue model
Name Day 0 Day 1 Day 4 Day 7 Day 8 Day 11 Day 14
Undifferentiated cells hASC seeded hASC medium  SFM + 25 µl HUVEC in SFM + 25 µl SFM + 25 µl  
 in hASC  + 25 µl Ficoll Ficoll EGM-2:  Ficoll Ficoll  
 medium on   4400 cells/cm2   
 48-well plate:  
Adipocyte culture 20,000 cells/  ATEm SM + 25 µl  SM + 25 µl MM + 25 µl Analysis  cm2 + 25 µl Ficoll Ficoll  Ficoll Ficoll
Vascularized adipose  ATEm + 25 µl SM + 25 µl HUVEC in SM + 25 µl MM + 25 µl 
tissue model  Ficoll Ficoll EGM-2: 4400  Ficoll Ficoll  
    cells/cm2 
Tab. 3: Chemicals used in this study
Chemical Product number/  Purity Concentrations tested CAS number Diluent 
 manufacturer
Rosiglitazone 71740/Cayman Chemical 99% 139.9; 44; 14; 4.4; 1.4; 0.44; 0.14; 0.044 µM 122320-73-4 0.5% DMSO
Chlorpyrifos 45395/SIGMA 99.7% 100; 31; 10; 3.1; 1; 0.3; 0.1; 0.03 µM 2921-88-2 0.5% ethanol
Prochloraz 45631/SIGMA 98.6% 5000; 1000; 500; 250; 50; 5; 0.5; 0.05 µM 67747-09-5 0.5% ethanol
Mancozeb 45553/SIGMA 97.5% 0.5; 0.16; 0.05; 0.016; 0.005; 0.0015; 0.0005;  8018-01-7 medium 
   0.00015 µg/ml
Butylparaben PHR1022/SIGMA 99.7% 500; 158; 50; 16; 5; 1.5; 0.5; 0.15 µg/ml 94-26-8 medium
15-Deoxy-Δ12, D8440/SIGMA 98.2% 3.15; 1; 0.315; 0.1; 0.0315; 0.01; 0.003;  87893-55-8 0.5% DMSO 
14-prostaglandin    0.001 µg/ml   
J2
Bisphenol A 239658/SIGMA 99.9% 99.4; 31.45; 9.95; 3.15; 0.5; 0.3; 0.0995;  80-05-7 0.5% DMSO 
   0.03 µg/ml
Bis-(2-Ethylhexyl)   36735/SIGMA 99.7% 100; 31.6; 10; 31.7; 1; 0.32; 0.1; 0.0032 µg/ml 117-81-7 0.5% DMSO 
phthalate  
Tributyltin 45713/SIGMA 97.3% 325.5; 103; 32.5; 10.3; 3.25; 1.04; 0.33;  1461-22-9 0.5% DMSO 
chloride   0.11 ng/ml  
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(Carl Zeiss), and images were further processed with ZEN 2012 
software (Carl Zeiss). All image types were further processed us-
ing Adobe Photoshop CS3 software (Adobe Systems Incorporat-
ed, San Jose, CA, USA).
In order to investigate the area of tubular networks, cell cul-
tures were imaged with Cell-IQ (CM Technologies Oy, Tampere, 
Finland) as described earlier (Huttala et al., 2018). Briefly, cul-
ture plates were imaged with a 10x objective and 5x5 grid per 
well. Grids were stitched together with Cell-IQ Analyzer (CM 
Technologies Oy) and further analyzed with ImageJ software 
(National Institutes of Health (NIH), Bethesda, MD, USA). Im-
ages were converted to an 8-bit gray scale, the background was 
subtracted and binary threshold was adjusted to determine the 
total tubule area in pixels. The fluorescence from adipocytes was 
removed from the count by size and circularity restrictions. This 
analysis method does not take length, number, or branch points 
of structures into consideration. Hence, the analysis focuses only 
on changes in the area covered by the vascular network. 
Gene expression studies
Expression of adipose tissue-related genes Glut1, PPARγ, leptin, 
Glut4, FABP4, PPARα, adiponectin, and PPARγ2 was studied 
as follows. Gene expression studies of insulin exposed cultures 
were performed by adding 500 µM insulin for 24 h into the cul-
ture prior to RNA isolation. RNA isolation was performed using 
the Purelink RNA mini kit (Invitrogen, Carlsbad, CA, USA) and 
PCR was performed with ITaq universal SYBR green one-step 
kit (Biorad, Hercules, CA, USA), both according to the manu-
facturer’s instructions. Each reaction contained 30 ng of the tem-
plate and 300 nM primer concentration. Primer sequences and 
annealing temperatures are shown in Table S11. A melt curve 
analysis was performed in each run. PCR amplification was per-
formed with CFX96 Real-Time System (Biorad). Results were 
calculated with the ΔΔCt method 36B4 as housekeeping gene. 
Unexposed and insulin exposed samples were analyzed using 
undifferentiated cells as control. The chemical exposed cultures 
were compared to a corresponding vehicle control.
Fluidigm analysis of vessel related genes
The developmental stage of vasculature in the model was further 
analyzed with a panel of 30 genes by Fluidigm system. Genes an-
alyzed were VEGFA, VEGFR-2/FLK-1, VEGFR-1/FLT-1, FGF2, 
FGFR2, EGFL7, EGFR, DLL4, Notch 1, Notch 4, AGGF1, 
PDGF, PDGFRb, ANGPT1, ANGPT2, TIE2, Dkk1, SMO, TGFB, 
TGFBR1, CD34, VE-cadherin 5, GJA1, occludin, fibronectin, 
ITGA5, CSPG4 /NG2, S1PR1, eNOS, and HPRT. Results were 
produced as concentrations based on the standard curve and nor-
malized to housekeeping gene GAPDH.
Integrity of the RNA samples was confirmed by using a 2100 
Bioanalyzer (Agilent, Santa Clara, CA, USA) and the concentra-
tion of the samples was measured with a NanoDrop 1000 Spec-
trophotometer (Thermo Fisher Scientific). cDNA synthesis was 
performed using Reverse Transcriptase Master mix (Fluidigm, 
South San Francisco, CA, USA) according to the manufacturer’s 
was determined by dividing AdipoRed values by WST-1 values. 
To calculate the amount of lipid per cell, absorbance values were 
first normalized to the average of the absorbance values of nega-
tive samples of each run. 
Secretion of proteins, i.e., leptin, adiponectin and FABP4, was 
compared between the adipocyte culture and the vascularized ad-
ipose tissue model. Medium samples were analyzed with ELISA 
kits for adiponectin, leptin and FABP4 (cat#DRP300, DLP00 and 
DFBP40, R&D Systems, Abingdon, UK) according to the manu-
facturer’s instructions. 
Glucose uptake and lipolysis
The glucose uptake test was performed as follows: On day 14, 
DMEM/F12 (Gibco) was changed on the cells and incubated 
for 2 h at 37°C with 5% CO2. Then cells were exposed to 
100 nM or 500 nM insulin and incubated at 37°C with 5% CO2 
for 30 min, and [3H]-2-deoxy-D-glucose (0.2 µCi/well, Perkin 
Elmer, Waltham, MA, USA) was added for another 20 min. The 
cells were lysed using 0.1% sodium dodecyl sulfate. The radioac-
tivity of the samples was measured by liquid scintillation counter 
Wallac1410 (Perkin Elmer) using OptiPhase HiSafe 2 oscillation 
liquid (Perkin Elmer). 
Lipolysis, i.e., glycerol release, was analyzed using the En-
zyChrom Adipolysis Assay Kit (BioAssay Systems, Hayward, 
CA, USA) according to the manufacturer’s instructions. On day 
14, DMEM/F12 (Gibco) was changed. After one hour, 2 µM iso-
proterenol was added and incubated for two hours after which 100 
nM or 500 nM insulin (Sigma, Saint Louis, MO, USA) was added. 
After 15 min or 30 min incubation, medium was collected and 
fluorescence was measured with a Varioskan™ Flash Multimode 
Reader (Thermo Fisher Scientific) at Iex 530 nm and Iem 585nm. 
Visualization of vasculature by immunocytochemical staining
The immunocytochemical staining was performed as described 
earlier (Huttala et al., 2015) except that the fixative used here 
was 4% formaldehyde at room temperature for 20 min. Antibod-
ies used were anti-von Willebrand factor IgG (produced in rab-
bit, Sigma), anti-collagen IV IgG (produced in mouse, Sigma), 
FITC-labeled goat polyclonal anti-mouse IgG (Sigma), and 
TRITC-labeled goat polyclonal anti-rabbit IgG (Sigma). In ad-
dition, for confocal imaging, anti-collagen IV (produced in rab-
bit, ab6586, Abcam, Cambridge, UK) used with secondary an-
tibody TRITC-labeled goat polyclonal anti-rabbit IgG (Sigma), 
CD140b-PE (BD Biosciences, 558821), and CD144-FITC (BD 
Biosciences, 560411) were used. Nuclei were stained using Flu-
oroshield™ with DAPI mounting medium (Sigma).
Microscopy and quantification of the vascular structures
Microscopic imaging was done with a Nikon Eclipse Ti-s invert-
ed fluorescence microscope (Nikon, Tokyo, Japan) and Nikon 
digital sight DS-U2-camera (Nikon), and images were further 
processed with NIS Elements (Nikon), ZEN 2012 software (Carl 
Zeiss, Oberkochen, Germany). Confocal imaging was done with 
LSM710 and with Zeiss Axio Observer Z1 inverted microscope 
1 doi:10.14573/altex.1811271s
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culture and the vascularized adipose tissue model contained lipid 
accumulating cells, which the undifferentiated cells did not con-
tain (Fig. 1). Upon morphological inspection, the lipid accumu-
lation in the vascularized adipose tissue model was more even-
ly spread out than in adipocyte culture, where there were fewer 
adipocytes that contained larger lipid storages. This morphology 
was also described in our previous study (Huttala et al., 2018) 
but could not be confirmed by the quantitative results of lipid per 
cell measurements (Fig. 1). Of the secreted proteins studied, ad-
iponectin was significantly increased in the vascularized adipose 
tissue model (Fig. 1), but the secretion of leptin and FABP4 was 
similar in both models.
3.2  Faster lipolysis response to insulin in 
the vascularized adipose tissue model
The responses to insulin were studied in both culture models 
to determine the influence of the vasculature. Inhibition of lip-
olysis by insulin was found to be faster in the vascularized adi-
pose tissue model, starting within 15 min in response to 500 nM 
(Fig. 2), while it only started after 30 min in the adipocyte cul-
ture. Both cultures equally increased glucose uptake in response 
to insulin (Fig. 2).
When comparing the vascularized adipose tissue model and 
adipocyte culture at gene expression level, Glut1 and leptin were 
significantly upregulated in the vascularized adipose tissue mod-
el (Fig. 3). However, there was no difference in secreted leptin 
between the cultures (Fig. 1). 
In gene expression analysis of the effect of insulin on both 
models, Glut1 was shown to be significantly down regulated 
in response to insulin in the vascularized adipose tissue model 
(Fig. 3). In addition, a trend towards an upregulation of Glut4 
and FABP4 in response to insulin can be seen for both cultures. 
Leptin and adiponectin expression increased slightly but not sig-
nificantly in the vascularized adipose tissue model in response to 
insulin. PPARα, PPARγ2 and general PPARγ expression did not 
respond to insulin.         
3.3  Markers of different stages of vascular formation 
present in vascularized adipose tissue model 
The vascularization was analyzed in the vascularized adipose 
tissue model with immunostaining and expression analysis of 
a panel of angiogenesis related genes. The gene panel was also 
analyzed in insulin-challenged samples. The vascular network 
in the vascularized adipose tissue model was well formed as 
seen in the collagen IV staining in Figure 4. Both CD144, i.e., 
ve-cadherin, and CD140b, i.e., PDGFRb, were expressed as ex-
pected in well-developed vasculature (Fig. 4). CD144 junctions 
are located in the tubules and CD140b on the surface of the tu-
bules. CD140b indicates the presence of pericytes that have been 
shown to be present in the vascular structures previously (Hutta-
la et al., 2015). 
Gene expression results show the presence of ongoing angio-
genesis as well as mature tubules (Tab. S31). The individual genes 
that were upregulated (2-fold or more compared to the non-insu-
lin treated cultures) in response to insulin were PDGF, FGFR2, 
and ve-cadherin 5 (Tab. S31). In the vascularized adipose tissue 
model prior to insulin exposure, PDGF and ve-cadherin were ex-
instructions on a T100 thermal cycler (Biorad). The “no template” 
control contained water instead of total RNA. In the “no amplifi-
cation” controls, the Reverse Transcriptase Master Mix was omit-
ted. The cDNA synthesis reaction was performed with 50 ng of to-
tal RNA. Pre-amplification was performed using PreAmp Master 
Mix (Fluidigm) and the instructions provided from Fluidigm for 
“Fast Gene Expression Analysis Using EvaGreen” using 60°C as 
annealing temperature on a T100 thermal cycler (Biorad). Primers 
were designed with Primer3 software. Amplicons were designed 
to overlap intron sequences where possible. Amplicons were de-
signed to be between 100-250 bp in length. Exonuclease I treat-
ment was performed with Exonuclease I (E. coli) (Lot no 0201507, 
New England Biolabs, Ipswich, MA, USA) on a T100 thermal 
cycler (Biorad). After the exonuclease treatment, 10 mM Tris- 
0.1 mM EDTA was added to give a 10-fold dilution of the 
cDNA, “no template” and “no amplification” control samples.
For gene expression analysis, 96.96 Dynamic Array Chip for 
Gene Expression (Fluidigm) was utilized according to the man-
ufacturer’s instruction using Fluidigm IFC Controller HX (Flu-
idigm) and BioMark HD (Fluidigm). Sample pre-mixes were 
prepared by mixing 2x SsoFast EvaGreen Supermix with low 
ROX (Biorad), Supermix with low ROX (Biorad 172-5211), 20X 
DNA Binding Dye (Fluidigm 100-7609), preamplified and Exo 
1-treated samples. Sample pre-mixes were then added to sam-
ple inlets of the primed 96.96 IFC. Assay mixes contained 2X 
Assay Loading Reagent (Fluidigm, 100-7611), 10 mM Tris-0.1 
mM EDTA buffer, and 100 µM forward and reverse primer mix 
(primer sequences Tab. S21). Assay mixes were added to assay 
inlets of the primed 96.96 IFC. The 96.96 IFC was then loaded to 
the Fluidigm Biomark HD selecting the Gene Expression, ROX, 
single probe, EvaGreen, and GE 96x96 PCR+Melt v1 Thermal 
protocol. Results were analyzed using Fluidigm’s BioMark Data 
Collection Analysis program (version 4.1.3). 
Statistical analyses
All calculations were done in Microsoft Excel 2010 (Microsoft 
Corporation, Redmond, WA, USA) and statistical analyses were 
done in GraphPad Prism (GraphPad Software Inc., La Jolla, CA, 
USA). Results are depicted as mean ± standard deviation; statis-
tical significance is expressed as *, p < 0.05 ; **, p < 0.01; and 
***, p < 0.001. Results from triglyceride accumulation (n = 5), 
ELISA (n = 6), glucose uptake (n = 5), lipolysis (n = 3), and one-
step RT-qPCR (n = 6, in insulin exposure n = 3) were subjected 
to one-way analysis of variance (ANOVA) followed by Fisher’s 
LSD test.
3  Results
3.1  The vascularized adipose tissue model shows 
increased secretion of adiponectin but similar 
lipid accumulation and secretion of leptin and 
FABP4 compared to the adipocyte culture 
The characteristics of the novel vascularized adipose tissue mod-
el were compared to those of adipocyte culture. Both were differ-
entiated with a modified protocol of the previously published in 
vitro adipocyte model (Huttala et al., 2016). Both the adipocyte 
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drial activity/viability determined by WST-1 increased in adipo-
cyte culture (EC50 7.97 µM) but no effect was seen in the vas-
cularized adipose tissue model in the tested concentration range 
of 0.0100-140 µM. Only a slight effect of rosiglitazone was seen 
on lipid accumulation in both models, with lipids increasing at a 
higher concentration in vascularized adipose tissue model than in 
adipocyte culture. There was an increase in tubules in response 
to rosiglitazone at the lower concentrations up to 1.4 µM, but no 
pressed at lower levels than the housekeeping gene. FGFR2 was 
already upregulated before insulin exposure. 
3.4  The effect of the adipogenesis stimulator 
rosiglitazone on gene expression
Rosiglitazone was used to test the response of the vascularized 
adipose tissue model to adipogenesis stimulators (Fig. 5). The 
model was exposed to rosiglitazone for 7 days. The mitochon-
Fig. 1: Morphology, lipid accumulation and secretion of adiponectin, leptin and FABP4 in the vascularized adipose tissue  
model at day 14 
A) Morphology of the different cultures stained with AdipoRed. Top: undifferentiated hASC-HUVEC co-culture; middle: adipocyte culture 
differentiated from hASC; bottom: vascularized adipose tissue model; scale bar 100 µm. B) Lipids accumulated per cell. Secretion  
of C) adiponectin, D) leptin, and E) FABP4. 
Fig. 2: Response of adipocyte culture and vascularized adipose tissue model to insulin at day 14 
A) Change in glucose uptake in response to 100 nM and 500 nM insulin. B) Inhibition of lipolysis 15 min and 30 min after exposure to  
100 and 500 nM insulin. Ins, insulin
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3.5  Effects of prochloraz and chlorpyrifos on 
the vascularized adipose tissue model 
The effects of prochloraz and chlorpyrifos were studied in a simi-
lar manner to rosiglitazone after 7 days exposure time. Prochloraz 
was toxic with an EC50 of 182.2 µM in adipocyte culture and 
181.6 µM in the vascularized adipose tissue model (Fig. 6). Inhi-
bition of lipid accumulation in adipocyte culture reached EC50 
at 164 µM and for the vascularized adipose tissue model at 187.2 
µM. No effect on the vasculature was observed at the tested con-
statistically significant angiogenic effect was seen at the studied 
concentration range of 0.0100-140 µM. The vascular network 
was intact and well branched in all exposed cultures. 
Gene expression of FABP4 and adiponectin greatly increased 
in response to 4.4 µM rosiglitazone compared to the correspond-
ing unexposed cultures in both the adipocyte culture and the vas-
cularized adipose tissue model. Glut4 was also slightly upregu-
lated in both cultures. The expression of leptin was increased in 
the vascularized adipose tissue model.       
Fig. 3: Expression of adipose tissue related genes (Glut1, PPARγ, leptin, Glut4, FABP4, PPARα, adiponectin, and  
PPARγ2) with or without 500 nM insulin in the adipocyte culture compared to the vascularized adipose tissue model at day 14
ins, insulin
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Fig. 4: Confocal images of vascularization in the vascularized 
adipose tissue model at day 14 
Top row: CD144 (green), i.e., ve-cadherin junctions can be found 
in the tubules surrounded by collagen IV stained basement 
membrane (red). Nuclei stained with DAPI (blue). Bottom row: 
CD140b (green), i.e., PDGFRb staining aligns along the tubules 
together with collagen IV staining (red). Scale bars 100 µm.
Fig. 5: Response of the adipocyte culture and the vascularized adipose tissue model to rosiglitazone 
A) Mitochondrial activity/viability measured with WST-1. B) Lipid accumulation analyzed by AdipoRed. C) The area of vasculature shown 
for example concentrations of rosiglitazone. D) Gene expression in the adipocyte culture and the vascularized adipose tissue model after 
exposure to 4.4 µM rosiglitazone. The red line indicates the level of unexposed corresponding cultures.
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Fig. 6: Response of the adipocyte culture and the vascularized adipose tissue model to prochloraz and chlorpyrifos 
A) Expression of selected genes after exposure to 50 µM prochloraz. The red line indicates the level of unexposed cells. B) Mitochondrial 
activity/viability measured with WST-1 (EC50 of 182.2 µM in the adipocyte culture and 181.6 µM for the vascularized adipose tissue  
model). C) Lipid accumulation measured with AdipoRed (EC50 of 48.54 µM for adipocyte culture and 73.51 µM for vascularized adipose 
tissue model). D) Expression of selected genes after exposure to 10 µM chlorpyrifos. Red line indicates the level of unexposed cells.  
E) Mitochondrial activity/viability. F) Lipid accumulation. 
Tab. 4: EC50 values for chemicals obtained in the vascularized adipose tissue model 
EC50, half maximal effective concentration
Chemical EC50  Mitochondrial EC50 lipid  Adipogenesis Angiogenesis  
 mitochondrial  activity (increase/ accumulation (inhibitor/  (increase/decrease) 
 activity decrease)  stimulator)
Mancozeb  90.24 µg/ml decrease 84.01 µg/ml inhibitor increase at non-toxic  
     concentrations
Butylparaben 433.8 µg/ml decrease 340.8 µg/ml inhibitor no effect
15-Deoxy-Δ12,14- 2.675 µg/ml increase 0.1038 µg/ml inhibitor increase at higher 
prostaglandin J2     concentrations
Bisphenol A 65.3 µg/ml decrease 0.5442 µg/ml inhibitor increase at higher non-toxic  
     concentrations
Bis-(2-ethylhexyl)   0.1634 µg/ml decrease 0.03 µg/ml and inhibitor significant increase 
phthalate   10 µg/ml (biphasic effect) 
Tributyltin chloride 106.2 ng/ml increase 312.8 ng/ml stimulator inhibition at lower  
     concentrations
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upregulation of the adipocyte-related genes PPARγ and PPARγ2, 
adiponectin, FABP4, leptin and Glut4. Genes that are less rele-
vant in adipocytes (Glut1 and PPARα) were not upregulated; 
hence the expression pattern correlates with a human white ad-
ipose tissue expression profile. The adipocytes also secreted 
leptin, FABP4 and adiponectin, which are also produced by na-
tive adipose tissue. The results showed that lipolysis was inhibit-
ed and glucose uptake increased in response to insulin as expect-
ed. Vascularization was seen to induce a faster lipolysis inhibition 
response to insulin and also had an effect on responses to chem-
icals. Based on these parameters, the vascularized adipose tissue 
model depicts the characteristics of adipose tissue well.
The importance of vascularization on adipose tissue has been 
shown in multiple studies. Especially the changes in vasculature 
in disease conditions are an important step in disease progres-
sion. Vasculature has been shown to counteract obesity and even 
insulin resistance when induced with VEGF (Robciuc et al., 
2016; Elias et al., 2012). In our study, the results showed that 
adding vascularization into the model induced an upregulation 
of Glut1 and leptin. This is in line with an anti-obesity effect of 
vasculature, as the hormone leptin regulates energy balance, sup-
pressing food intake and thereby inducing weight loss (Halaas 
et al., 1995). Glut1 on the other hand is a non-insulin dependent 
glucose transporter, which is found in a variety of tissues includ-
ing fetal and adult tissues, red blood cells, endothelia and mus-
cle (Huang et al., 2015; Ciaraldi et al., 2005; Olson and Pessin, 
1996). Hence the upregulation seen here is likely due to the pres-
ence of Glut1 in the vascular endothelial cells. Angiogenic ves-
sels are known to produce various cytokines and growth factors 
that promote adipogenesis (Varzaneh et al., 1994), which further 
enable the success of the adipogenesis process.
When developing relevant adipose tissue cell models, the 
source of cells is crucial. In 2016, Ruiz-Odeja et al. noted that 
most in vitro adipose models are still based on mouse 3T3-L1 
cells (Ruiz-Ojeda et al., 2016). These are stable cell lines but not 
suitable when aiming for the human relevant models. For human 
models, one commonly utilized cell type is the human adipose 
stromal cell population isolated from human fat (Ruiz-Ojeda et 
al., 2016). These are primary, human cells as are those used in 
our study.
The use of primary cells has its concerns, as there is the pos-
sibility of lot-to-lot variations. When using primary cells, each 
isolated cell lot should be tested against quality criteria set for the 
cells in question. With increasing knowledge of cell type specif-
ic marker expression, more relevant quality control criteria can 
be defined. One recent example is the marker CD142, which can 
suppress adipogenesis, that has been found be expressed in hASC 
(Schwalie et al., 2018). Through quality control, CD142-positive 
cells could be purified from the population to study adipogenesis. 
On the other hand, the diversity of the population could be seen 
as an advantage, making the population more relevant for human 
studies.
The role of the extracellular matrix (ECM) composition has 
been brought up in the context of in vitro models and differen-
tiation of stem cells. Our vascular network has been shown to 
produce ECM in the culture (Huttala et al., 2015) and the stain-
ing for collagen IV was positive in the current vascularized ad-
centrations of 0.01-5000 µM. Exposure to 50 µM prochloraz in-
creased the expression of PPARα significantly in the vascular-
ized adipose tissue model. Other studied markers were expressed 
on a lower level than in the unexposed cultures.
Chlorpyrifos caused viability/mitochondrial activity to in-
crease with an EC50 of 48.54 µM for adipocyte culture and 
73.51 µM for the vascularized adipose tissue model (Fig. 6). 
Chlorpyrifos seemed to inhibit lipid accumulation at lower con-
centrations and increase it at the higher concentrations before 
inhibiting it again. No effect on the amount of vasculature was 
detected. Expression of leptin was significantly higher in the 
vascularized adipose tissue model than in adipocyte culture after 
exposure to 10 µM chlorpyrifos.  
3.6  Results of further chemical tests
To test further the responses of the vascularized adipose tissue 
model, the model was exposed to six more chemicals for 7 days. 
These were analyzed for lipid accumulation, mitochondrial ac-
tivity, and amount of vasculature only in the vascularized adi-
pose tissue model. Results of these chemicals can be found in 
Table 4. The effect on angiogenesis is determined from the 
changes in the total area of vasculature. 
4  Discussion
Our previous study found two suitable methods for combining 
adipocytes and vascularization to produce a vascularized adi-
pose tissue model (Huttala et al., 2018). Of these previously pub-
lished methods, one was further modified here to reach a ma-
ture adipocyte marker expression profile at the end of the 14-day 
culture period. The vascularized adipose tissue model present-
ed here utilized the same differentiation protocol that produced 
insulin responsive adipocytes (Huttala et al., 2016) with a few 
modifications. The differences to the previously published pro-
tocol (Huttala et al., 2016) were the additional medium change 
at day 8 and the addition of the macromolecule ficoll to the me-
dia. Now this differentiation protocol can be used to differentiate 
adipocyte culture from hASC and induce both angiogenesis and 
adipogenesis in a co-culture of hASC and HUVEC. This allows 
the comparison of the effects of vascularization in adipose tissue 
in for example mechanistic studies, as the only variable between 
the adipocyte culture and the vascularized adipose tissue model 
is the presence of vascularization.
This in vitro human vascularized adipose tissue model was 
studied at gene, protein, and functional levels, and results were 
compared to the adipocyte culture. Functional tests included in-
sulin and chemical responses. The vascularized adipose tissue 
model was exposed to nine chemicals and their effect on lipid 
accumulation, mitochondrial activity/viability, and vasculariza-
tion was quantified. Both models were exposed to three of these 
chemicals, i.e., rosiglitazone, prochloraz, and chlorpyrifos; and 
these cultures were also analyzed for gene expression. 
The presence of the key biological characteristics confirmed 
that the vascularized adipose tissue model mimics the in vivo adi-
pose tissue characteristics and functional properties well. The ad-
ipocytes in the model accumulated triglycerides and showed an 
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vesicles from intracellular storage sites to the plasma membrane, 
where they dock and fuse (Bryant et al., 2002; Watson and Pessin, 
2007) for glucose uptake. To ensure that central insulin respons-
es were present in the culture, both the adipocyte culture and the 
vascularized adipose tissue model were exposed to insulin. Re-
sponses to insulin were confirmed by the increased uptake of glu-
cose and inhibition of lipolysis. The lack of a further increase in 
glucose uptake with higher insulin concentration (Fig. 2) is most 
likely due to a negative feedback response to insulin hyperstimu-
lation (Ma et al., 2013). The response time to lipolysis inhibition 
was found to be shorter in the vascularized adipose tissue mod-
el. As discussed above, the increase in vasculature has previous-
ly been shown to protect from insulin resistance (Robciuc et al., 
2016; Elias et al., 2012) and our result of a faster response seems 
to support these findings. In our results (Fig. 2), the level of se-
creted triglycerides was slightly higher in the vascularized adipose 
tissue model than in the adipocytes alone, with little or no insulin 
addition. Robciuc et al. found that the induction of excess vascu-
lature improved lipid metabolism and linked the activated VEGF/
VEGFR2 pathway to better insulin responses in adipose tissue and 
a higher basal metabolic rate (Robciuc et al., 2016). In our results, 
VEGFR2 is upregulated and increases in response to insulin (Tab. 
S31). This further supports the hypothesis that a similar mecha-
nism of improved lipid metabolism is seen in our in vitro model 
and would explain the increased lipolysis when little or no insulin 
is present in the vascularized adipose tissue model.
At gene expression level, the exposure to insulin led to up- 
regulation of Glut4 and FABP4 in both the adipocyte culture 
and the vascularized adipose tissue model. The increase of 
FABP4 would indicate that some adipocytes were still maturing 
as FABP4 is the indicator of late stage adipogenesis (Gregoire 
et al., 1998). Glut4 is the insulin dependent glucose transport-
er (Birnbaum, 1989; James et al., 1989) and hence the upregu-
lation would be expected. In contrast, Glut1 was downregulated 
in the vascularized adipose tissue model. In mouse 3T3-L1 cells, 
Glut1 mRNA is upregulated in response to insulin (Sargeant 
and Paquet, 1993). It has also been shown that the expression of 
Glut1 in 3T3-L1 cells is downregulated as ECM rigidity decreas-
es, whereas the Glut4 mRNA levels do not respond to the rigidity 
(Li et al., 2009), which would probably be closer to the situation 
in our vascularized adipose tissue model than the plastic rigidity. 
It has also been reported that there is a negative feedback loop 
between the expression of Glut1 and Glut4 (Ebeling et al., 1998). 
Also, there are studies which show no change in Glut1 expression 
in response to insulin (Machado et al., 1994). The response of 
Glut1 should be studied further to confirm the result.
In vasculature, insulin induces an upregulation of PDGF, FG-
FR2, and ve-cadherin (Tab. S31). Since PDGF recruits pericytes 
and ve-cadherin is a tight junction protein, it would seem that in-
sulin increases the maturation of vessels. It has been shown that 
in retinal neovascularization a reduction of IGF-1 expression 
leads to an increase of the angiogenic markers angiotensin II and 
VEGF (Li et al., 2018). Perhaps the opposite happens with insu-
lin exposure, as mature vessels are needed for a functioning glu-
cose homeostasis.
In response to rosiglitazone, gene expression of FABP4, adi-
ponectin and Glut4 was elevated in both cultures. The expression 
ipose tissue model. Gene expression results (Tab. S31) showed 
that the vasculature contains tubules in all different developmen-
tal phases of angiogenesis, including mature vascular structures 
expressing PDGFRb and ANPGT1, which would indicate that 
the tubules also have a basal lamina layer. Due to the vast vas-
cularization of adipose tissue, the basal membrane collagen IV 
is one component of natural adipose tissue ECM (Nakajima et 
al., 2002). As the vascularized adipose tissue model expresses a 
variety of angiogenesis related genes, it can be utilized to study 
the angiogenic potential of chemicals in addition to adipogenic 
properties.
The utilization of macromolecular crowding in cultures has 
been shown to enhance the accumulation of ECM (Zeiger et al., 
2012; Chen et al., 2011). We used ficoll as a macromolecule, aided 
by the presence of BSA in the medium. The combination of these 
large molecules had a similar effect on the culture as is aimed for 
in the concept of macromolecular crowding. Protein concentra-
tions of in vivo interstitial fluids could be 30-70 g/l (Bates et al., 
1993) and although the concentrations used here were not high 
enough to lead to corresponding protein concentrations, an effect 
was seen in the better handling properties of the resulting model. 
The premature detachment issues encountered earlier (Huttala et 
al., 2018) no longer occur since we use ficoll. This would indicate 
that ECM proteins are accumulated in the cultures where they 
provide better attachment sites to the cells. Detachment of cells in 
tissue models is a serious problem when considering the applica-
bility and reliability of the model. Detection of the possible effect 
of a chemical on adipogenesis and/or angiogenesis is not possible 
if the cells detach. Previous studies have reported that serum-free 
medium combined with macromolecular ficoll crowding is not 
beneficial for the cells (Patrikoski et al., 2017); however, we ob-
served positive effects of ficoll in our study, probably due to the 
lower concentration of the crowders. Although we use human 
serum, serum-free medium would be beneficial as it enables de-
fined culture conditions. Such serum-free defined medium has 
been developed recently and was shown to produce vascularized 
adipose tissue in vitro (Volz et al., 2018).
In addition to the natural composition of the in vivo environ-
ment, the stiffness of the surface on which the cells grow influ-
ences the cells. It has been shown that cells grown on low stiff-
ness matrix are more likely to become adipocytes than cells seed-
ed on stiffer matrices (Winer et al., 2009; Chun et al., 2006). The 
ECM produced by the vasculature would lead to the low stiffness 
platform for the adipocytes to grow on. The vascularized adipose 
tissue model presented here shows improvement in the expres-
sion of key adipose tissue genes compared to the previously pub-
lished model (Huttala et al., 2018). The model presented here al-
so shows secretion of the adipocyte proteins leptin, adiponectin 
and FABP4, which are secreted by young (few lipid vacuoles) 
and mature (one big lipid vacuole) adipocytes, indicating the rel-
evance of this model in depicting mature white adipose tissue.
The interactions between tissues are important in creating in vi-
vo-like in vitro tissue models. The influence of these interactions 
is seen, for example, in altered insulin responses in muscle cells 
caused by adipokines secreted by adipocytes (Kudoh et al., 2018). 
In native adipose tissue, insulin represses lipolysis in adipocytes 
(Choi et al., 2010) and leads to translocation of Glut4-containing 
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increased it at higher concentrations before inhibiting it again. It 
has been reported that chlorpyrifos decreases lipid accumulation 
in 3T3 cells (Taxvig et al., 2012). In our experiments, leptin ex-
pression was significantly increased in the vascularized adipose 
tissue model exposed to 10 µM chlorpyrifos and this effect has 
been shown by others on released leptin protein levels using the 
same concentration of chlorpyrifos (Taxvig et al., 2012). No an-
giogenic response to chlorpyrifos was observed in our study or 
reported elsewhere (Jeon et al., 2016).
The six additional studied chemicals induced various respons-
es in the vascularized adipose tissue model. Tributyltin chloride 
increased lipid accumulation as reported in literature (Biemann et 
al., 2014; Pereira-Fernandes et al., 2013). Mancozed, which has 
been reported to decrease body weight (Kwon et al., 2018), in-
hibited lipid accumulation in our model. Bisphenol A has been 
shown to decrease mitochondrial activity and triglyceride accu-
mulation (Biemann et al., 2012) in concordance with our results, 
although contrary results have also been reported (Ariemma et 
al., 2016). Based on the literature, butyl paraben (Pereira-Fer-
nandes et al., 2014), 15-deoxy-Δ12,14-prostaglandin J2 and 
bis-(2-ethylhexyl) phthalate (Biemann et al., 2012) were expect-
ed to increase lipid accumulation, but the opposite was seen in 
our vascularized adipose tissue model. 
The effects of the study chemicals were also assessed in terms 
of their influence on the amount of vasculature in the vascularized 
adipose tissue model after exposure to the chemicals. The results 
obtained in our model correlated well with the results reported in 
the literature. In addition to expected angiogenic responses ob-
served in response to rosiglitazone, prochloraz and chlorpyrifos, 
the response to the following substances was also as expected 
based on literature: butylparaben (no effect), bisphenol A, man-
cozed and tributyltin. Bisphenol A has been described to induce 
tubule formation (Tait et al., 2015; Helmestam et al., 2014) but 
can also inhibit tubule formation depending on the concentration 
(Tait et al., 2015). In our results, an induction was seen at higher 
concentrations. Manconzeb has been found to influence the TIE2 
pathway (Kleinstreuer et al., 2011) and in our model the effect of 
mancozeb was seen as a slight induction of angiogenesis. Tribu-
tyltin chloride has been shown to influence ICAM and hence the 
angiogenesis process (Hu et al., 2015); a slight inhibition of an-
giogenesis was seen in the tubule formation in our model. Based 
on these results, our vascularized adipose tissue model can also 
predict the angiogenic effects of chemicals in adipose tissue. 
On the contrary, the results obtained upon challenge with 
bis-(2-ethylhexyl) phthalate and 15-deoxy-Δ12,14-prostaglandin 
J2 were different from those expected on the basis of literature 
reports. Bis-(2-ethylhexyl) phthalate has been shown to decrease 
PlGF and increase the soluble VEGFR-1:PlGF ratio in the fetus, 
which would indicate inhibition of angiogenesis (Ferguson et 
al., 2015); however, we found induction of angiogenesis. 15-De-
oxy-Δ12,14-prostaglandin J2 has been reported to be an anti-an-
giogenic factor that induces endothelial cell apoptosis, although 
the mechanism remains unclear (Ho et al., 2008), but the oppo-
site was seen in our model where higher concentrations induced 
angiogenesis. The effects of these two chemicals should also be 
studied on gene expression level to confirm the result and correla-
tion with previous results.
of leptin was also increased in the vascularized adipose tissue 
model. Our vascularized adipose tissue model shows good con-
cordance with the findings of others on the effects of rosiglita-
zone on adipocytes. Taxvig et al. (2012) showed that rosiglita-
zone increases the expression of leptin and adiponectin with no 
effect on PPARα. Rosiglitazone is also used for the induction of 
adipogenesis (Cheng et al., 2016; Foley et al., 2015), hence it was 
expected that markers of mature adipose tissue would increase. 
Thiazolidinediones, like rosiglitazone, are also known to enhance 
Glut4 action (Martinez et al., 2010). Although we did not see the 
increase in PPARγ expression or lipid accumulation described 
by others (Taxvig et al., 2012), the gene expression changes in 
our model support increased adipogenesis. It is possible that with 
a longer exposure time or a longer culture time after exposure 
(here 7 days exposure), an increased lipid accumulation would be 
seen. To further improve the vascularized adipose tissue model 
presented here, it might be possible to lower the concentration 
of troglitazone. Compared to our previously published adipocyte 
protocol (Huttala et al., 2016), we added one additional change 
of troglitazone medium here and this could be masking some of 
the lipid accumulating effects of the chemicals even though ef-
fects were seen on gene expression level. Regarding vascular-
ization, there are studies that show an increase in adipose tissue 
vascularization upon in vivo exposure of humans to rosiglita-
zone (Gealekman et al., 2012) as well as inhibition of endothelial 
proliferation, migration, and angiogenesis in vitro (Sheu et al., 
2006). The quantification of vascular network formed in our vas-
cularized adipose tissue model showed an increase in angiogene-
sis in response to rosiglitazone, which is in concordance with the 
in vivo exposure data.
We found that prochloraz was equally cytotoxic in the adipo-
cyte culture and the vascularized adipose tissue model. In the 
adipocyte culture, an inhibition of lipid accumulation was seen 
at non-cytotoxic concentrations, EC50 being 164 µM, however 
inhibition of lipid accumulation was only seen at toxic concentra-
tions in the vascularized adipose tissue model. In the vascularized 
adipose tissue model, the expression of PPARα increased, where-
as expression of other studied markers decreased compared to the 
unexposed cultures. Previous results have shown that prochloraz 
decreases adiponectin and leptin expression and decreases lipid 
accumulation in 3T3-L1 adipocytes already at 50 µM (Taxvig 
et al., 2012). Taxvig et al. did not see any effect on PPARα or 
PPARγ in their study (Taxvig et al., 2012). The increased level of 
PPARα in the vascularized adipose tissue model is an intriguing 
finding. The results of Taxvig et al. (2012) were obtained with a 
monoculture of mouse adipocytes and hence the difference may 
be due to the presence of vasculature. PPARα is also found in 
endothelial cells (Bishop-Bailey and Swales, 2008) and the acti-
vation of endothelial PPARα could be one reason for the upregu-
lation seen here. However, this would likely impair angiogenesis, 
which was not observed by us or by others (Kleinstreuer et al., 
2011). Further mechanistic studies are needed to confirm the rea-
son for PPARα upregulation.
Chlorpyrifos caused an increase in the viability/mitochondri-
al activity with EC50 of 48.54 µM for the adipocyte culture and 
73.51 µM for the vascularized adipose tissue model. Chlorpyrifos 
seemed to inhibit lipid accumulation at lower concentrations and 
Huttala et al.
ALTEX 36(3), 2019 432
Cao, Y. (2013). Angiogenesis and vascular functions in modu-
lation of obesity, adipose metabolism, and insulin sensitivity. 
Cell Metab 18, 478-489. doi:10.1016/j.cmet.2013.08.008
Cao, Y. (2014). Angiogenesis as a therapeutic target for obesity 
and metabolic diseases. Chem Immunol Allergy 99, 170-179. 
doi:10.1159/000353254
Chandrasekera, P. C. and Pippin, J. J. (2014). Of rodents and 
men: Species-specific glucose regulation and type 2 diabetes 
research. ALTEX 31, 157-176. doi:10.14573/altex.1309231
Chen, C., Loe, F., Blocki, A. et al. (2011). Applying macromolec-
ular crowding to enhance extracellular matrix deposition and 
its remodeling in vitro for tissue engineering and cell-based 
therapies. Adv Drug Deliv Rev 63, 277-290. doi:10.1016/j. 
addr.2011.03.003
Cheng, B., Wu, M., Xu, S. et al. (2016). Cocktail supplement 
with rosiglitazone: A novel inducer for chicken preadipocyte 
differentiation in vitro. Biosci Rep 36, 1-11. doi:10.1042/
BSR20160049
Choi, S. M., Tucker, D. F., Gross, D. N. et al. (2010). Insulin 
regulates adipocyte lipolysis via an Akt-independent sig-
naling pathway. Mol Cell Biol 30, 5009-5020. doi:10.1128/
MCB.00797-10
Christiaens, V. and Lijnen, H. R. (2010). Angiogenesis and de-
velopment of adipose tissue. Mol Cell Endocrinol 318, 2-9. 
doi:10.1016/j.mce.2009.08.006
Chun, T. H., Hotary, K. B., Sabeh, F. et al. (2006). A pericel-
lular collagenase directs the 3-dimensional development of 
white adipose tissue. Cell 125, 577-591. doi:10.1016/j.cell. 
2006.02.050
Ciaraldi, T. P., Mudaliar, S., Barzin, A. et al. (2005). Skeletal 
muscle GLUT1 transporter protein expression and basal leg 
glucose uptake are reduced in type 2 diabetes. J Clin Endocri-
nol Metab 90, 352-358. doi:10.1210/jc.2004-0516
Ebeling, P., Koistinen, H. A. and Koivisto, V. A. (1998). Insu-
lin-independent glucose transport regulates insulin sensitiv-
ity. FEBS Lett 436, 301-303. doi:10.1016/S0014-5793(98) 
01149-1
Elias, I., Franckhauser, S., Ferre, T. et al. (2012). Adipose tissue 
overexpression of vascular endothelial growth factor protects 
against diet-induced obesity and insulin resistance. Diabetes 
61, 1801-1813. doi:10.2337/db11-0832
Ferguson, K. K., McElrath, T. F., Cantonwine, D. E. et al. (2015). 
Phthalate metabolites and bisphenol-A in association with cir-
culating angiogenic biomarkers across pregnancy. Placenta 
36, 699-703. doi:10.1016/j.placenta.2015.04.002
Foley, B., Clewell, R. and Deisenroth, C. (2015). Development 
of a human adipose-derived stem cell model for characteri-
zation of chemical modulation of adipogenesis. Appl In Vitro 
Toxicol 1, 66-78. doi:10.1089/aivt.2014.0007
Gealekman, O., Guseva, N., Gurav, K. et al. (2012). Effect of 
rosiglitazone on capillary density and angiogenesis in adipose 
tissue of normoglycaemic humans in a randomised controlled 
trial. Diabetologia 55, 2794-2799. doi:10.1007/s00125-012-
2658-2
Gregoire, F. M., Smas, C. M. and Sul, H. S. (1998). Under-
standing adipocyte differentiation. Physiol Rev 78, 783-809. 
doi:10.1152/physrev.1998.78.3.783
5  Conclusion
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regard to safety testing of chemicals, drug development, and bio-
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cell-based models is evident based on the species differences. In 
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vant results. The vascularized adipose tissue model developed 
here is a valuable research model as it is a relevant replacement 
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The vascularized adipose tissue model presented here con-
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